Showing results (1-10 of 217) with videos related to
Sort By:
Pageof 22
Pharmaceutical Research|April 2, 2013
A physiologically based pharmacokinetic model for strontium exposure in ratHenry Pertinez, Marylore Chenel, Leon AaronsJournal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDesMarylore Chenel, François Bouzom, Leon Aarons, et al.The AAPS Journal|November 22, 2014
Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptyingKayode Ogungbenro, Henry Pertinez, Leon AaronsJournal of Pharmacokinetics and Pharmacodynamics|December 13, 2005
Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trialMarylore Chenel, Kayode Ogungbenro, Vincent Duval, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.Journal of Biopharmaceutical Statistics|April 5, 2014
Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokineticsCyrielle Dumont, Marylore Chenel, France MentréFrontiers in Oncology|July 31, 2013
Influence of the duration of intravenous drug administration on tumor uptakeSylvain Fouliard, Marylore Chenel, Fabrizio MarcucciThe AAPS Journal|November 14, 2019
Application of Item Response Theory to Model Disease Progression and Agomelatine Effect in Patients with Major Depressive DisorderMarc Cerou, Sophie Peigné, Emmanuelle Comets, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 19, 2015
Model-based approaches for ivabradine development in paediatric population, part II: PK and PK/PD assessmentSophie Peigné, Sylvain Fouliard, Sophie Decourcelle, et al.Biometrics|November 5, 2011
Some alternatives to asymptotic tests for the analysis of pharmacogenetic data using nonlinear mixed effects modelsJulie Bertrand, Emmanuelle Comets, Marylore Chenel, et al.Pageof 22